Reference
Athanasoulia-Kaspar AP, et al. Neuropsychiatric and metabolic aspects of dopaminergic therapy: Perspectives from an endocrinologist and a psychiatrist. Endocrine Connections 7: R88-R94, No. 2, Feb 2018. Available from: URL: http://doi.org/10.1530/EC-18-0030 - Germany
Rights and permissions
About this article
Cite this article
Bromocriptine/cabergoline/quinagolide. Reactions Weekly 1696, 70 (2018). https://doi.org/10.1007/s40278-018-44258-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-44258-8